Skip to main content
Caplight Logo









OpticSurg

OpticSurg

Private
New York City, New YorkHealthcare & Life Scienceshttps://opticsurginc.com

Last Round

Seed

Sep 1, 2020

Company Overview

OpticSurg operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in September 2020.

OpticSurg is a healthcare technology company that develops an augmented reality and artificial intelligence-enabled software platform to facilitate telecollaboration and improve surgical and patient care workflows.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OpticSurg Comparables

Compare OpticSurg with similar companies based on industry and business-model similarity.

OpticSurg comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
83%
eXeX
83%
MediView XR, Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OpticSurg Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

OpticSurg Investors

Notable investors and investment history

OpticSurg investors
InvestorRounds
Pride Fund 1Seed
Loud CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2025

    Grew 30% QoQ, from 10 to 13 employees.

  • May 13, 2024

    Grew 27% QoQ from 11 to 14 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

OpticSurg Filings

Explore SEC and related filing metadata, where available.

OpticSurg filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OpticSurg's valuation, stock price, and market status.

Is OpticSurg a public or private company?

OpticSurg is a private company.

What is the current stock price of OpticSurg?

OpticSurg is a private company, so its shares have no public market price. Caplight tracks OpticSurg's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OpticSurg worth (valuation)?

Valuation information for OpticSurg is not publicly available.

Can I buy OpticSurg stock?

OpticSurg shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OpticSurg's last funding round?

OpticSurg's most recent funding round was Seed on September 1, 2020.

Who are the main investors in OpticSurg?

Key investors in OpticSurg include Pride Fund 1, Loud Capital.

Will OpticSurg IPO soon?

No public IPO plans have been announced for OpticSurg.

How can I track OpticSurg secondary market activity?

Caplight tracks bids, offers, and trades in OpticSurg's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range8
Year Founded2017
Last FundingSep 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?